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ASYMPTOTIC PROPERTIES OF THE SEQUENTIAL EMPIRICAL
ROC, PPV AND NPV CURVES UNDER
CASE-CONTROL SAMPLING1
By Joseph S. Koopmeiners and Ziding Feng
University of Minnesota and Fred Hutchinson Cancer Research Center
The receiver operating characteristic (ROC) curve, the positive
predictive value (PPV) curve and the negative predictive value (NPV)
curve are three measures of performance for a continuous diagnostic
biomarker. The ROC, PPV and NPV curves are often estimated em-
pirically to avoid assumptions about the distributional form of the
biomarkers. Recently, there has been a push to incorporate group
sequential methods into the design of diagnostic biomarker studies.
A thorough understanding of the asymptotic properties of the sequen-
tial empirical ROC, PPV and NPV curves will provide more flexibil-
ity when designing group sequential diagnostic biomarker studies. In
this paper, we derive asymptotic theory for the sequential empirical
ROC, PPV and NPV curves under case-control sampling using se-
quential empirical process theory. We show that the sequential empir-
ical ROC, PPV and NPV curves converge to the sum of independent
Kiefer processes and show how these results can be used to derive
asymptotic results for summaries of the sequential empirical ROC,
PPV and NPV curves.
1. Introduction. Several recent papers have discussed the application of
group sequential methodology to diagnostic biomarker studies [Tang, Emer-
son and Zhou (2008), Tang and Liu (2010), Pepe et al. (2009)]. Group se-
quential study designs (i.e., study designs with multiple interim analyses)
provide an opportunity to improve the efficiency of diagnostic biomarker
studies by allowing studies to terminate early when the candidate marker
is clearly superior or inferior to established markers or historical levels of
marker performance. Many group sequential methods assume the existence
of a test statistic with an independent increments covariance structure [Jen-
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nison and Turnbull (2000)]. A thorough understanding of the asymptotic
properties of the sequential empirical ROC, PPV and NPV curves and,
specifically, verifying that their summary measures have an independent in-
crements covariance structure, would provide great flexibility when designing
group sequential diagnostic biomarker studies.
Diagnostic biomarkers are used to classify a patient as a case or a con-
trol. A dichotomous biomarker results in either a positive test, indicating
that the subject should be classified as a case, or a negative test, indi-
cating that the subject should be classified as a control. Many biomarkers
are measured on a continuous scale and a threshold must be defined in
order to translate a continuous biomarker into a positive or negative test
result. Let D be a Bernoulli random variable indicating disease status with
prevalence ρ and let X be a biomarker value with conditional distribution
F (x|D = 1) ≡ FD(x) and F (x|D = 0) ≡ FD¯(x), where FD(x) is the distri-
bution function for the cases and FD¯(x) is the distribution function for the
controls. Furthermore, we define F (x) ≡ FD(x) + (1 − ρ)FD¯(x) to be the
biomarker distribution function for the entire population. Without loss of
generality, assume that larger biomarker values are more indicative of dis-
ease. For a threshold c, a biomarker value X is translated into a positive
test result if it is greater than c and a negative test result if it is less than
or equal to c.
The receiver operating characteristic (ROC) curve summarizes the clas-
sification accuracy of a continuous diagnostic biomarker [Pepe (2003)] by
reporting the true positive fraction (TPF) and the false positive fraction
(FPF) for all possible cut-offs of the marker. For a threshold c, TPF(c) =
P [X > c|D = 1] and FPF(c) = P [X > c|D = 0]. The ROC curve is defined as
ROC(c) = {(TPF(c),FPF(c)), c ∈ (−∞,∞)}
and can alternately be expressed as
ROC(t) = SD(S
−1
D¯
(t)), t ∈ (0,1),(1.1)
where SD(x) = 1−FD(x) and SD¯(x) = 1−FD¯(x). ROC(t) can be interpreted
as the TPF corresponding to a FPF of t. Alternately, one might be interested
in the inverse of the ROC curve,
ROC−1(v) = SD¯(S
−1
D (v)), v ∈ (0,1).(1.2)
ROC−1(v) is indexed by the TPF and can be interpreted as the FPF corre-
sponding to a TPF of v.
The predictive accuracy of a dichotomous biomarker can be summarized
by the positive predictive value (PPV) and negative predictive value (NPV).
The PPV and NPV curves were proposed as an extension of PPV and NPV
to continuous markers [Moskowitz and Pepe (2004), Zheng et al. (2008)].
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For a threshold c, PPV(c) = P [D = 1|X > c] and NPV(c) = P [D = 0|X ≤ c].
The PPV and NPV curves are defined as PPV(c) and NPV(c) for all c ∈
(−∞,∞). In practice, PPV and NPV curves are indexed by a summary of
the marker distribution rather than a generic threshold [Moskowitz and Pepe
(2004), Zheng et al. (2008)]. In this paper, we consider the PPV and NPV
curves indexed by the FPF and the percentile value in the entire population.
The ROC, PPV and NPV curves are commonly estimated nonparamet-
rically to avoid making assumptions about the form of FD(x) and FD¯(x).
This is particularly important in the case of the ROC, PPV and NPV curves
because we are often interested in regions of the curve that correspond to the
tails of these distributions. For example, a biomarker must possess a high
specificity in order to be clinically useful in a low disease risk population
screening setting, which corresponds to the upper tail of the biomarker dis-
tribution among controls.
Our understanding of the empirical ROC curve is enhanced by knowledge
of its asymptotic properties. Hsieh and Turnbull (1996) showed that the
empirical ROC curve converges to the sum of two independent Brownian
bridges. The asymptotic normality of summary measures of the empirical
ROC curve, such as the area under the ROC curve or a point on the ROC
curve, can be derived from their work. To our knowledge, no asymptotic
theory is available for the empirical PPV and NPV curves.
Tang, Emerson and Zhou (2008) showed that a family of weighted area
under the ROC curve (wAUC) statistics has an independent increments co-
variance structure. It would be beneficial to show that this assumption holds
for a larger class of summaries of the ROC curve. In this paper, we develop
asymptotic theory for the sequential empirical ROC, PPV and NPV curves.
Our results allow us to develop distribution theory for other summaries of
the ROC curve and to develop distribution theory for summaries of the PPV
and NPV curves.
2. Notation and definitions. Before beginning our discussion of the se-
quential empirical ROC, PPV and NPV curves, we provide definitions of
the sequential empirical estimates for the underlying distribution and quan-
tile functions. Let XD,1,XD,2, . . . ,XD,nD be i.i.d. marker values for the
cases with distribution function, FD(x), and XD¯,1,XD¯,2, . . . ,XD¯,nD¯ be i.i.d.
marker values for the controls with distribution function, FD¯(x). Further-
more, let rD and rD¯ refer to the proportion of case and controls, respectively,
that are observed at a given time point. The sequential empirical estimate
of FD(x) is defined as
FˆD,rD(x) =


0, 0≤ rD < 1
nD
,
1
[rDnD]
[rDnD ]∑
i=1
1{XD,i ≤ x}, −∞< x<∞, 1
nD
≤ rD ≤ 1,
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and the sequential empirical estimate of F−1D (t) is defined as
Fˆ−1D,rD(t) =


XD,1,[rDnD], if t= 0,0≤ rD ≤ 1,
XD,k,[rDnD], if
k− 1
[rDnD]
< t≤ k
[rDnD]
,
1≤ k ≤ [rDnD],0≤ t≤ 1,
where XD,1,[rDnD],XD,2,[rDnD ], . . . ,XD,[rDnD ],[rDnD] are the sequential order
statistics of the biomarker values for the cases. The sequential empirical
estimates of SD(x) and S
−1
D (t) are defined as SˆD,rD(x) = 1− FˆD,rD(x) and
Sˆ−1D,rD(t) = Fˆ
−1
D,rD
(1− t). The sequential empirical estimates for the control
population are defined in an analogous fashion. The sequential empirical
estimates of FD(x) and FD¯(x) lead to a natural definition of the sequential
empirical estimates of F (x) and F−1(t),
FˆrD ,rD¯(x) = ρFˆD,rD(x) + (1− ρ)FˆD¯,rD¯(x)
and
Fˆ−1rD ,rD¯
(t) = inf{x : FˆrD,rD¯(x)≥ t},
where ρ is assumed to be known. FˆrD ,rD¯(x) is a linear combination of FˆD,rD(x)
and FˆD¯,rD¯(x) and is therefore indexed by both rD, the proportion of cases
observed at a given time point, and rD¯, the proportion of controls observed
at a given time point.
Throughout this paper, we let 0 < a < b < 1, 0 < c < 1, 0 < d < 1 and
make the following assumptions:
(A1) FD(x) and FD¯(x) are continuous distribution functions with con-
tinuous densities fD(x) and fD¯(x), respectively,
(A2) fD(x)> 0 for x ∈ (sup{x :FD(x) = 0}, inf{x :FD(x) = 1}),
(A3) fD¯(x)> 0 for x ∈ (sup{x :FD¯(x) = 0}, inf{x :FD¯(x) = 1}),
(A4) nDnD¯
→ λ > 0 as nD→∞ and nD¯→∞, that is, the ratio of cases to
controls converges to a constant that is greater than 0.
The asymptotic results in Section 3 make use of the Kiefer process. The
Kiefer process, K(t, r), is a two-dimensional, mean-zero Gaussian process
with covariance
Cov(K(t1, r1),K(t2, r2)) = (t1 ∧ t2− t1t2)(r1 ∧ r2),
where ∧ represents the minimum. The Kiefer process behaves like a Brow-
nian bridge in t and Brownian Motion in r.
The remainder of this paper proceeds as follows. In Section 3, we de-
velop asymptotic theory for the sequential empirical ROC, PPV and NPV
curves. First, we generalize the work of Hsieh and Turnbull (1996) to the
sequential empirical ROC curve by showing that the sequential empirical
ROC curve converges to the sum of independent Kiefer processes. Next,
we develop asymptotic theory for the sequential empirical PPV and NPV
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curves indexed by the FPF by writing them as functions of the sequential
empirical ROC curve. Finally, we follow the approach of Pyke and Shorack
(1968) to develop asymptotic theory for the PPV and NPV curves indexed
by the percentile value of the marker distribution. We validate our asymp-
totic results by simulation in Section 4 and illustrate how they can be used
to design group sequential diagnostic biomarker studies in Section 5. We
conclude with a discussion in Section 6.
3. Asymptotic results.
3.1. The sequential empirical ROC curve. In this section, we provide
asymptotic results for the sequential empirical ROC curve. Results for the
inverse of the sequential empirical ROC curve are nearly identical; we di-
rect the reader to an associated technical report for details [Koopmeiners
and Feng (2010)]. The sequential empirical ROC curve, R̂OCrD,rD(t), is de-
fined by substituting the sequential empirical estimates of SD(x) and SD¯(x)
into (1.1), yielding
R̂OCrD ,rD¯(t) = SˆD,rD(Sˆ
−1
D¯,rD¯
(t)),
and for ease of notation, we define
RrD,rD¯(t)≡ n
−1/2
D [nDrD](R̂OCrD,rD¯(t)−ROC(t)).
The primary result in this section provides asymptotic theory for RrD,rD¯(t).
By developing asymptotic theory for RrD,rD¯(t), we are also able to develop
asymptotic theory for functionals of RrD,rD¯(t) as a special case. Theorem 3.1
establishes the convergence of RrD ,rD¯(t) to the sum of independent Kiefer
processes.
Theorem 3.1. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. As nD→∞ and nD¯→∞
RrD,rD¯(t)→d K1(ROC(t), rD) + λ1/2
rD
rD¯
(
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
)
K2(t, rD¯)
uniformly for t ∈ [a, b], rD ∈ [c,1] and rD¯ ∈ [d,1] where K1 and K2 are in-
dependent Kiefer processes.
A proof of Theorem 3.1 can be found in the Appendix. Theorem 3.1
generalizes the results of Hsieh and Turnbull (1996) to the sequential empir-
ical ROC curve. The proof of Theorem 3.1 is similar to the proof found in
Hsieh and Turnbull (1996) but our proof relies on the more powerful sequen-
tial empirical process theory. Sequential empirical process theory generalizes
asymptotic theory for the standard empirical process by introducing a pa-
rameter for time. In doing so, asymptotic results for the sequential empirical
process involve the Kiefer process. Using properties of the Kiefer process, we
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are able to easily derive asymptotic results for summaries of the sequential
empirical ROC curve and verify that the independent increments assump-
tion holds in many cases. Furthermore, we can recover Hsieh and Turnbull’s
result as a special case of Theorem 3.1 by letting rD and rD¯ both equal 1.
Corollary 3.2. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. As nD→∞ and nD¯→∞,
R1,1(t)→d B1(ROC(t)) + λ1/2
(
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
)
B2(t)
uniformly for t ∈ [a, b] where B1 and B2 are independent Brownian bridges.
Proof. Immediate from Theorem 3.1 and by noting that K(t,1) =d
B(t). 
An advantage to studying the asymptotic behavior of the sequential em-
pirical ROC curve at the process level, rather than a single point on the
sequential empirical ROC curve, is that we are able to study the joint be-
havior of multiple points on the ROC curve. Corollary 3.3 provides a normal
approximation for a vector of points on the sequential empirical ROC curve.
Corollary 3.3. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. For t1, t2, . . . , tJ ∈ (0,1), rD,1, rD,2, . . . , rD,J ∈ (0,1] and rD¯,1, rD¯,2,
. . . , rD¯,J ∈ (0,1], a vector of arbitrary points on the sequential empirical ROC
curve, (R̂OCrD,1,rD¯,1(t1), R̂OCrD,2,rD¯,2(t2), . . . , R̂OCrD,J ,rD¯,J (tJ)), is approx-
imately multivariate normal with
R̂OCrD,j,rD¯,j (tj)∼N(ROC(tj), σ2R̂OCrD,j,rD¯,j (tj)
), j = 1,2, . . . , J,
where
σ2
R̂OCrD,j,rD¯,j (tj)
=
ROC(tj)(1−ROC(tj))
nDrD,j
+
(
fD(S
−1
D¯
(tj))
fD¯(S
−1
D¯
(tj))
)2
tj(1− tj)
nD¯rD¯,j
and
Cov[R̂OCrD,i,rD¯,i(ti), R̂OCrD,j ,rD¯,j(tj)]
=
(rD,i ∧ rD,j)(ROC(ti)∧ROC(tj)−ROC(ti)ROC(tj))
nDrD,irD,j
+
(
fD(S
−1
D¯
(ti))
fD¯(S
−1
D¯
(ti))
)(
fD(S
−1
D¯
(tj))
fD¯(S
−1
D¯
(tj))
)
(rD¯,i ∧ rD¯,j)(ti ∧ tj − titj)
nD¯rD¯,irD¯,j
.
Proof. Immediate from Theorem 3.1. 
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Corollary 3.3 provides the asymptotic covariance for two points at dif-
ferent locations and different times on the sequential empirical ROC curve.
This allows us to fully specificy the joint sequential distribution of multi-
ple points on the ROC curve, which allows us to design group sequential
diagnostic biomarker studies where multiple points on the ROC curve are
treated as multiple endpoints of a group sequential study. For example, we
might be interested in ROC(t1) and ROC(t2), where t1 is chosen for high
specificity to rule patients in for work up and t2 is chosen for high sensitivity
to rule out patients for invasive work.
Our interest in the sequential empirical ROC curve is motivated by the
need to design group sequential diagnostic biomarker studies. Our ability
to design group sequential diagnostic biomarker studies would be enhanced
by showing that summaries of the sequential empirical ROC curve have an
independent increments covariance structure. The simplest summary of the
ROC curve is a point on the ROC curve, ROC(t). ROC(t) can be inter-
preted as the sensitivity at a specificity of 1− t. Corollary 3.4 shows that
the sequential empirical estimator of ROC(t) is asymptotically normal and
has independent increments when divided its variance.
Corollary 3.4. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. For t ∈ (0,1) and J stopping times, (R̂OCrD,1,rD¯,1(t), R̂OCrD,2,rD¯,2(t),
. . . , R̂OCrD,J ,rD¯,J (t)), is approximately multivariate normal with
R̂OCrD,i,rD¯,i(t)∼N(ROC(t), σ2R̂OCrD,i,rD¯,i (t)
), i= 1,2, . . . , J,
and
Cov[R̂OCrD,i,rD¯,i(t), R̂OCrD,j ,rD¯,j (t)]
= Var[R̂OCrD,j,rD¯,j (t)] = σ
2
R̂OCrD,j,rD¯,j (t)
, ri ≤ rj ,
where σ2
R̂OCrD,j,rD¯,j (t)
is defined as in Corollary 3.3.
Proof. Immediate from Corollary 3.3. 
Asymptotic theory for other summary measures of the ROC curve, such
as the area under the curve or the partial area under the curve, can also
be derived from Theorem 3.1. This illustrates the flexibility of Theorem 3.1.
By developing distribution theory for the sequential empirical ROC curve,
we are able to derive distribution theory for summaries of the ROC curve
as a special case.
3.2. The sequential empirical PPV and NPV curves indexed by the false
positive fraction. In this section, we consider the sequential empirical PPV
and NPV curves indexed by the false positive fraction, t. The PPV and NPV
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curve indexed by the false positive fraction can be written as a function of
the ROC curve and their asymptotic properties can be derived using the
results from Section 3.1. Asymptotic results for the PPV and NPV curve
indexed by the true positive fraction, v, can similarly be derived by writing
the PPV and NPV curve as a function of the inverse of the ROC curve
but are not presented in this paper. The interested reader is directed to
Koopmeiners and Feng (2010) for details.
The PPV and NPV curves indexed by the false positive fraction are de-
fined as PPV(t) = P [D = 1|X >S−1
D¯
(t)] and NPV(t) = P [D = 0|X ≤ S−1
D¯
(t)]
for all t ∈ (0,1) and can be written as functions of the ROC curve as follows:
PPV(t) =
ROC(t)ρ
ROC(t)ρ+ t(1− ρ)(3.1)
and
NPV(t) =
(1− t)(1− ρ)
(1−ROC(t))ρ+ (1− t)(1− ρ) .(3.2)
The sequential empirical estimators of PPV(t) and NPV(t) are defined be
plugging the sequential empirical estimator of ROC(t) into (3.1) and (3.2),
yielding
P̂PVrD,rD¯(t) =
R̂OCrD ,rD¯(t)ρ
R̂OCrD ,rD¯(t)ρ+ t(1− ρ)
and
N̂PVrD ,rD¯(t) =
(1− t)(1− ρ)
(1− R̂OCrD,rD¯(t))ρ+ (1− t)(1− ρ)
.
From this point forward, we only consider P̂PVrD,rD¯(t) and note that results
for N̂PVrD,rD¯(t) are nearly identical. Again, for ease of notation, we define
PrD,rD¯(t)≡ n
−1/2
D [nDrD](P̂PVrD,rD¯(t)−PPV(t)).
We begin by using the results of Section 3.1 to derive asymptotic theory
for PrD ,rD¯(t). Theorem 3.5 establishes the convergence of PrD,rD¯(t) to the
sum of two independent Kiefer processes.
Theorem 3.5. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. As nD→∞ and nD¯→∞
PrD ,rD¯(t)→d
(
t(1− ρ)ρ
(ROC(t)ρ+ t(1− ρ))2
)
×
(
K1(ROC(t), rD) + λ
1/2 rD
rD¯
(
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
)
K2(t, rD¯)
)
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uniformly for t ∈ [a, b], rD ∈ [c,1] and rD¯ ∈ [d,1] where K1 and K2 are in-
dependent Kiefer processes.
The proof of Theorem 3.5 relies on writing PrD,rD¯(t) as a function
of RrD,rD¯(t)
PrD,rD¯(t) =
(
R̂OCrD ,rD¯(t)ρ
R̂OCrD ,rD¯(t)ρ+ t(1− ρ)
− ROC(t)ρ
ROC(t)ρ+ t(1− ρ)
)
× (R̂OCrD,rD¯(t)−ROC(t))−1RrD,rD¯(t)
and applying the results of Theorem 3.1. The first term converges to(
t(1− ρ)ρ
(ROC(t)ρ+ t(1− ρ))2
)
and RrD,rD¯(t) converges to the sum of two independent Kiefer process by
Theorem 3.1. A formal proof of Theorem 3.5 can be found in Koopmeiners
and Feng (2010).
From Theorem 3.5, we can prove analogous results to Corollaries 3.3
and 3.4 for the sequential empirical PPV curve indexed by the FPF. Namely,
that an arbitrary vector of points on the sequential empirical PPV curve fol-
lows a multivariate normal distribution and the sequential empirical estimate
of a point on the PPV curve is approximately normally distributed with an
independent increments covariance structure. We leave the formal statement
of these corollaries for the Appendix but present the form of the covariance
between two arbitrary points on the sequential empirical PPV curve:
Cov[P̂PVrD,i,rD¯,i(ti), P̂PVrD,j,rD¯,j (tj)]
=
(
ti(1− ρ)ρ
(ROC(ti)ρ+ ti(1− ρ))2
)(
tj(1− ρ)ρ
(ROC(tj)ρ+ tj(1− ρ))2
)
×Cov[R̂OCrD,i,rD¯,i(ti), R̂OCrD,j,rD¯,j (tj)].
PPV(t) is a function of ROC(t) and, therefore, distribution theory for a vec-
tor of points on the PPV curve can also be derived using the delta method
and Corollary 3.3.
Asymptotic theory for the fixed-sample empirical PPV curve indexed by
the FPF, which was previously unavailable, can be derived as a special case
of Theorem 3.5 by letting rD and rD¯ equal 1. The fixed-sample empirical
PPV curve converges to the sum of independent Brownian bridges
P1,1(t)→d
(
t(1− ρ)ρ
(ROC(t)ρ+ t(1− ρ))2
)
×
(
B1(ROC(t)) + λ
1/2
(
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
)
B2(t)
)
,
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which allows us to derive a normal approximation for the empirical estimate
of a point on the PPV curve
P̂PV1,1(t)∼N
(
PPV(t),
(
t(1− ρ)ρ
(ROC(t)ρ+ t(1− ρ))2
)2
σ2
R̂OC1,1(t)
)
,
where σ2
R̂OC1,1(t)
is defined as in Corollary 3.3.
3.3. The sequential empirical PPV and NPV curves indexed by the per-
centile value. Finally, we consider the PPV and NPV curves indexed by the
proportion of the population that are classified as negative, u, and positive,
1−u. In this case, the PPV and NPV curves are defined as PPV(u) = P [D =
1|X >F−1(u)] and NPV(u) = P [D = 0|X ≤ F−1(u)] for all u ∈ (0,1). Under
this indexing, the PPV curve can be written as
PPV(u) =
SD(F
−1(u))ρ
1− u ,(3.3)
and since the NPV curve can be written as
NPV(u) =
u− ρ
u
+
1− u
u
PPV(u),(3.4)
it suffices to study the PPV curve when considering estimation of the NPV
curve.
The sequential empirical estimator of PPV(u) is found by substituting the
sequential empirical estimators of SD(x) and F (x), along with the known
value of ρ, into (3.3),
P̂PVrD,rD¯(u) =
SˆD,rD(Fˆ
−1
rD ,rD¯
(u))ρ
1− u ,(3.5)
and the sequential empirical estimator of NPV(u) is found by substituting
the sequential empirical estimator of PPV(u) into (3.4),
N̂PVrD ,rD¯(u) =
u− ρ
u
+
1− u
u
P̂PVrD ,rD¯(u).(3.6)
Finally, we define,
PrD ,rD¯(u) = n
−1/2
D [nDrD](P̂PVrD,rD¯(u)−PPV(u))
and
NrD,rD¯(u) = n
−1/2
D [nDrD](N̂PVrD,rD¯(u)−NPV(u))
for mathematical convenience. We begin by developing distribution theory
for PrD ,rD¯(u). Theorem 3.6 establishes the convergence of the sequential
empirical PPV curve to the sum of two independent Kiefer processes.
SEQUENTIAL EMPIRICAL ROC, PPV AND NPV CURVES 11
Theorem 3.6. Assume (A1)–(A4) hold and let fD(F
−1(u))
f(F−1(u))
be bounded
on [a, b]. As nD→∞ and nD¯→∞
PrD ,rD¯(u)→d −
ρ(1− ρ)
1− u
fD¯(F
−1(u))
f(F−1(u))
K1(FD(F
−1(u)), rD)
+
ρ(1− ρ)
1− u
fD(F
−1(u))
f(F−1(u))
√
λ
rD
rD¯
K2(FD¯(F
−1(u)), rD¯)
uniformly for u ∈ [a, b], rD ∈ [c,1] and rD¯ ∈ [d,1] where K1 and K2 are
independent Kiefer processes.
The proof of Theorem 3.6 is complicated by the fact that SˆD,rD(x)
and Fˆ−1rD ,rD¯(t) are correlated because FˆrD,rD¯(x) is a linear combination
of FˆD,rD(x) and FˆD¯,rD¯(x). In contrast, the sequential empirical ROC curve
and the sequential empirical PPV curve indexed by the FPF are functionals
of two independent sequential empirical estimators, SˆD,rD(x) and Sˆ
−1
D¯,rD¯
(t),
which makes it easier to show that RrD,rD¯(t) and PrD ,rD¯(t) converge to
the sum of independent Kiefer processes. To account for the correlation be-
tween SˆD,rD(x) and Fˆ
−1
rD ,rD¯
(t), we follow the approach of Pyke and Shorack
(1968), who prove a similar result for two correlated, fixed-sample empirical
processes. The proof of Theorem 3.6 can be found in the Appendix.
Theorem 3.6 also establishes asymptotic theory for the sequential empir-
ical NPV curve because N̂PVrD,rD¯(t) is a function of P̂PVrD,rD¯(t). Corol-
lary 3.7 establishes the convergence of NrD ,rD¯(t) to the sum of two indepen-
dent Kiefer processes.
Corollary 3.7. Assume (A1)–(A4) hold and let fD(F
−1(u))
f(F−1(u))
be bounded
on [a, b]. As nD→∞ and nD¯→∞
NrD,rD¯(u)→d −
ρ(1− ρ)
u
fD¯(F
−1(u))
f(F−1(u))
K1(FD(F
−1(u)), rD)
+
ρ(1− ρ)
u
fD(F
−1(u))
f(F−1(u))
√
λ
rD
rD¯
K2(FD¯(F
−1(u)), rD¯)
uniformly for u ∈ [a, b], rD ∈ [c,1] and rD¯ ∈ [d,1] where K1 and K2 are
independent Kiefer processes.
Corollary 3.7 is immediate from Theorem 3.6 by noting that
NrD ,rD¯(t) =
1− u
u
PrD ,rD¯(t).
As with the ROC curve and the PPV curve indexed by the FPF, Theorem 3.6
and Corollary 3.7 allow us to develop distribution theory for summaries of
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the PPV and NPV curve indexed by u. Distribution theory for a vector of
points on the PPV or NPV curve is left for the Appendix but we choose
to highlight the joint distribution of the sequential empirical estimate of
a single point on the PPV or NPV curve. Corollary 3.8 establishes that
the sequential empirical estimate of a point on the PPV or NPV curve is
asymptotically normal and has independent increments when divided by its
variance.
Corollary 3.8. Assume (A1)–(A4) hold and let fD(F
−1(u))
f(F−1(u))
be bounded
on [a, b]. For u ∈ (0,1) and J stopping times:
(A) (P̂PVrD,1,rD¯,1(u), P̂PVrD,2,rD¯,2(u), . . . , P̂PVrD,J ,rD¯,J (u)), is approxima-
tely multivariate normal with
P̂PVrD,i,rD¯,i(u)∼N(PPV(u), σ2P̂PVrD,i,rD¯,i (u)
), i= 1,2, . . . , J,
and
Cov[P̂PVrD,i,rD¯,i(u), P̂PVrD,j,rD¯,j (u)]
= Var[P̂PVrD,j ,rD¯,j(u)] = σ
2
P̂PVrD,j,rD¯,j (u)
, ri ≤ rj,
where
σ2
P̂PVrD,j,rD¯,j (u)
=
(
fD¯(F
−1(u))
f(F−1(u))
(1− ρ)
)2
PPV(u)
(
ρ
1− u −PPV(u)
)
× 1
nDrD,j
+
(
fD(F
−1(u))
f(F−1(u))
ρ
)2
(1−PPV(u))
(
u− ρ
1− u +PPV(u)
)
× 1
nD¯rD¯,j
.
(B) (N̂PVrD,1,rD¯,1(u), N̂PVrD,2,rD¯,2(u), . . . , N̂PVrD,J ,rD¯,J (u)), is approxima-
tely multivariate normal with,
N̂PVrD,i,rD¯,i(u)∼N(NPV(u), σ2N̂PVrD,i,rD¯,i(u)
), i= 1,2, . . . , J,
and
Cov[N̂PVrD,i,rD¯,i(u), N̂PVrD,j,rD¯,j (u)]
= Var[N̂PVrD,j ,rD¯,j(u)] = σ
2
N̂PVrD,j,rD¯,j (u)
, ri ≤ rj ,
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where
σ2
N̂PVrD,j,rD¯,j (u)
=
(
fD¯(F
−1(u))
f(F−1(u))
(1− ρ)
)2(
NPV(u) +
ρ− u
u
)
(1−NPV(u))
× 1
nDrD,j
+
(
fD(F
−1(u))
f(F−1(u))
ρ
)2
NPV(u)
(
1− ρ
u
−NPV(u)
)
× 1
nD¯rD¯,j
.
It is immediate from Theorem 3.6 and Corollary 3.7 that P̂PVrD,rD¯(u) and
N̂PVrD,rD¯(u) are asymptotically normal with an independent increments
covariance structure. By noting that
FD(F
−1(u)) = 1− 1− u
ρ
PPV(u) =
u
ρ
(1−NPV(u))
and
FD¯(F
−1(u)) = 1− 1− u
1− ρ (1−PPV(u)) =
u
1− ρ NPV(u),
we can write the asymptotic variances of P̂PVrD ,rD¯(u) and N̂PVrD,rD¯(u)
as functions of PPV(u) and NPV(u), respectively. This provides a better
understanding of the mean-variance relationship for the asymptotic distri-
butions of P̂PVrD ,rD¯(u) and N̂PVrD ,rD¯(u) and, perhaps, provides a form of
the variance that is easier to work with in practical situations (i.e., study
design, estimating the standard error, etc.).
An important component of Theorem 3.6 and Corollary 3.7 is that not
only do PrD ,rD¯(u) and NrD,rD¯(u) converge to the sum of independent Kiefer
processes, but they both converge to the same two Kiefer processes. As
a result, we are able to derive the correlation between a point on the PPV
curve and a point on the NPV curve. Corollary 3.9 provides a bivariate
normal approximation for a point on the PPV and a point on the NPV curve.
Corollary 3.9. Assume (A1)–(A4) hold and let fD(F
−1(u))
f(F−1(u))
be bounded
on [a, b]. For u1, u2 ∈ (0,1), (P̂PVrD,1,rD¯,1(u1), N̂PVrD,2,rD¯,2(u2)), is approx-
imately bivariate normally distributed with
P̂PVrD,1,rD¯,1(u1)∼N(PPV(u), σ2P̂PVrD,1,rD¯,1 (u1)
)
and
N̂PVrD,2,rD¯,2(u2)∼N(NPV(u), σ2N̂PVrD,2,rD¯,2(u2)
)
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with
Cov[P̂PVrD,1,rD¯,1(u1), N̂PVrD,2,rD¯,2(u2)]
=
(1− ρ)2u1(1− u2)
(1− u1)u2
fD¯(F
−1(u1))
f(F−1(u1))
fD¯(F
−1(u2))
f(F−1(u2))
× (rD,1 ∧ rD,2)(1−NPV(u1))PPV(u2)
nDrD,1rD,2
+
ρ2u1(1− u2)
(1− u1)u2
fD(F
−1(u1))
f(F−1(u1))
fD(F
−1(u2))
f(F−1(u2))
× (rD¯,2 ∧ rD¯,2)NPV(u1)(1−PPV(u2))
nDrD,1rD,2
,
when u1 ≤ u2 and
Cov[P̂PVrD,1,rD¯,1(u1), N̂PVrD,2,rD¯,2(u2)]
= (1− ρ)2 fD¯(F
−1(u1))
f(F−1(u1))
fD¯(F
−1(u2))
f(F−1(u2))
× (rD,1 ∧ rD,2)(1−NPV(u2))PPV(u1)
nDrD,1rD,2
+ ρ2
fD(F
−1(u1))
f(F−1(u1))
fD(F
−1(u2))
f(F−1(u2))
× (rD¯,2 ∧ rD¯,2)NPV(u2)(1−PPV(u1))
nDrD,1rD,2
,
when u2 ≤ u1, where σ2
P̂PVrD,1,rD¯,1 (u1)
and σ2
N̂PVrD,2,rD¯,2 (u2)
are defined as in
Corollary 3.8.
The case of a point on the PPV curve and a point on the NPV curve is
presented for simplicity but Corollary 3.9 can be extended to an arbitrary
vector of points on the PPV and NPV curves. Corollary 3.9 has obvious
practical implications. It is not uncommon to classify the bottom u1×100%
of the population as “low-risk,” the top (1− u2)× 100% of the population
as “high-risk” and the remainder of the population as “moderate-risk.” In
this case, one would be interested in the NPV of the low-risk group and the
PPV of the high-risk group. Corollary 3.9 provides the joint convergence of
these two estimates.
Finally, we note that asymptotic results for the fixed-sample empirical
PPV and NPV curves indexed by the percentile value of the marker dis-
tribution can be derived as a special case of the results in this section. It
is immediate from Theorem 3.6 and Corollary 3.7 that the fixed-sample
empirical PPV and NPV curves converge to the sum of independent Brow-
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Fig. 1. True ROC and PPV curves for the scenario considered in Section 4.
nian bridges by letting rD and rD¯ both equal 1. Furthermore, Corollary 3.8
provides a normal approximation for the fixed-sample empirical estimate of
a point on the PPV or NPV curve for the special case when J = 1.
4. Finite sample properties. A simulation study was completed to as-
sess the finite sample properties of the results in Theorems 3.1, 3.5 and 3.6.
We simulated 10,000 studies with nD¯ controls and nD cases. Biomarker val-
ues for the controls were drawn from a standard normal distribution and
biomarker values for the cases were drawn from a normal distribution with
mean and standard deviation equal to 1. A prevalence of 0.2 was used for esti-
mation of the PPV curve. Figure 1 presents the true ROC and PPV curves
for this scenario. For each realization, we calculated RrD,rD¯(t), PrD,rD¯(t)
and PrD ,rD¯(u) and evaluated the expected value, normality and covariance
for various combinations of rD, rD¯ and t or u. Normality was evaluated by
providing a summary of information found in a normal q-q plot. Instead of
providing the entire plot, we provide the (simulated) probability of being less
than the 5th, 25th, 50th, 75th and 95th percentile of a normal distribution
with variance derived using the results in Theorems 3.1, 3.5 and 3.6. Sim-
ilarly, the simulated covariance matrices were compared to the theoretical
covariance matrices derived using the results in Theorems 3.1, 3.5 and 3.6.
Table 1 presents simulation results for RrD,rD¯(t). The expected value was
close to 0 in all cases with only a small amount of bias observed when t= 0.2.
The probability of being less than the theoretical 5th and 95th percentile
was close to the nominal value for all sample sizes, while the probability of
being less than the 25th, 50th and 75th percentile was less than the nominal
value with 50 cases and 50 controls but approached the correct values as
sample size increases. The observed variance and covariance were less than
expected with 50 cases and 50 controls but the observed covariance matrix
approached the theoretical covariance matrix in larger sample sizes. This
phenomenon is likely due to the sample space for ROC(t) being restricted to
the unit interval. R̂OC(t) is less likely to equal 0 or 1 as sample size increases
and the normal approximation will be more accurate. Similar results were
observed for PrD,rD¯(t) and PrD ,rD¯(u) but were omitted for brevity.
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Table 1
Simulation results to evaluate the finite sample properties of Theorem 3.1. Presented are the expected value, simulated probability of
being less than 5th, 25th, 50th, 75th and 95th percentile of the normal distribution, the simulated covariance matrix and the theoretical
covariance matrix for RrD,rD¯ (t). 10,000 simulations were performed for each scenario
5th 25th 50th 75th 95th Observed Theoretical
Mean %tile %tile %tile %tile %tile covariance matrix covariance matrix
nD = 50, nD¯ = 50
R0.4,0.7(0.4) 0.01 0.05 0.17 0.46 0.63 0.98 0.1 0.117 0.079 0.103 0.104 0.129 0.081 0.104
R1,1(0.4) 0.02 0.07 0.2 0.44 0.74 0.97 0.318 0.104 0.262 0.322 0.104 0.26
R0.4,0.7(0.2) 0.03 0.04 0.22 0.47 0.73 0.96 0.161 0.201 0.171 0.225
R1,1(0.2) 0.05 0.04 0.2 0.47 0.68 0.93 0.544 0.563
nD = 100, nD¯ = 100
R0.4,0.7(0.4) 0.01 0.05 0.21 0.41 0.78 0.97 0.101 0.12 0.08 0.102 0.104 0.129 0.081 0.104
R1,1(0.4) 0.02 0.05 0.24 0.48 0.76 0.96 0.318 0.104 0.26 0.322 0.104 0.26
R0.4,0.7(0.2) 0.03 0.04 0.2 0.45 0.73 0.95 0.164 0.205 0.171 0.225
R1,1(0.2) 0.05 0.04 0.23 0.47 0.73 0.95 0.55 0.563
nD = 200, nD¯ = 200
R0.4,0.7(0.4) 0.01 0.06 0.22 0.44 0.7 0.96 0.104 0.121 0.081 0.102 0.104 0.129 0.081 0.104
R1,1(0.4) 0.02 0.05 0.25 0.48 0.72 0.95 0.317 0.104 0.259 0.322 0.104 0.26
R0.4,0.7(0.2) 0.03 0.04 0.25 0.5 0.7 0.94 0.168 0.212 0.171 0.225
R1,1(0.2) 0.05 0.05 0.23 0.46 0.72 0.95 0.555 0.563
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5. Application. The results of Section 3 provide fundamental theory that
allows existing group sequential methodology to be applied to summaries
of the ROC, PPV and NPV curves. In this section, we present an exam-
ple of how these results can be used to design group sequential diagnostic
biomarker studies. Our application is presented in the context of a study to
evaluate the diagnostic accuracy of des-gamma carboxyprothrombin (DCP),
a novel biomarker for the early detection of hepatocellular carcinoma (HCC).
A multi-center study was completed to compare the diagnostic accuracy of
DCP to that of alpha-fetoprotein (AFP), the most widely used biomarker
for the detection of HCC [Marrero et al. (2009)] but in our application we
will only consider the design of a study to compare DCP to historical levels
of diagnostic accuracy for AFP.
We consider a study to evaluate the predictive accuracy of DCP using
the following novel design that makes use of the joint asymptotic theory for
the PPV and NPV curve derived in Section 3.8. Assume that the prevalence
of HCC in the population of interest is 0.2. In this case, one might call
the bottom 60% percent of biomarker values “negative,” the top 10% of
the biomarker values “positive” and refer the remaining subjects for further
evaluation. Under this scenario, we would desire a high NPV for negative test
results, NPV(0.6), and a high PPV for positive test results, PPV(0.9). The
NPV(0.6) for AFP is 0.92 and the PPV(0.9) is 0.82. To determine if DCP
improves on the predictive accuracy of AFP, we would test the hypothesis,
H0: NPV(0.6)≤ 0.9 or PPV(0.9)≤ 0.8
versus
Ha: NPV(0.6)> 0.9 and PPV(0.9)> 0.8
using the test statistics, ZNPV(u1) and ZPPV(u2), where ZNPV(u1) is defined
as
ZNPV(u1) =
N̂PV(0.6)−NPV(0.6)0
σNPV(0.6)0
,
and ZPPV(u2) is defined in an analogous fashion.
We consider a group sequential design using the error spending approach
proposed by Hwang, Shih and De Cani (1990). The overall null hypothesis
will only be rejected if the null hypotheses for both NPV(0.6) and PPV(0.9)
are rejected. In the context of a group sequential study, this means that the
study will stop early to reject the null hypothesis if ZNPV(u1) and ZPPV(u2)
both cross the boundary for rejecting the null hypothesis but the study will
stop early for futility if either ZNPV(u1) or ZPPV(u2) cross the futility bound-
ary. This implies that we do not need to adjust the type-I error rate to
account for multiple endpoints but we do need to consider the joint proba-
bility of rejecting the null hypothesis when determining the power.
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Table 2
Simulation results to evaluate the operating characteristics of a study to evaluate the
predictive accuracy of DCP using a fixed-sample design and group sequential designs with
two, three or four stopping times. Presented are the probability of rejecting the null
hypothesis and expected sample size under the null and alternative hypotheses. 10,000
simulations were performed for each scenario
NPV(0.6) = 0.90 NPV(0.6) = 0.95 NPV(0.6) = 0.90 NPV(0.6) = 0.95
PPV(0.9) = 0.80 PPV(0.9) = 0.80 PPV(0.9) = 0.90 PPV(0.9) = 0.90
Stopping
times P (reject) E(nD) P (reject) E(nD) P (reject) E(nD) P (reject) E(nD)
J = 1 0.003 702 0.03 702 0.026 702 0.917 702
J = 2 0.004 432 0.026 492.4 0.024 489.5 0.924 624.5
J = 3 0.004 367.4 0.022 431.3 0.023 433 0.917 580.1
J = 4 0.002 340 0.023 410.7 0.024 417.2 0.911 571.1
The sample size for our study is chosen to achieve 90% power under the
alternative hypothesis NPV(0.6) = 0.95 and PPV(0.9) = 0.90. A closed-form
formula for determining the required sample size is not available. Instead,
the sample size for a fixed sample design is derived by numerically solving
P (ZNPV(u1) >Z1−α/2,PPV(u2)>Z1−α/2|NPV(u1) = 0.95,PPV(u2) = 0.90)
for nD, where the joint distribution of ZNPV(u1) and ZPPV(u2) is derived
by applying the delta method to the joint asymptotic normal distribution
of N̂PVrD,rD¯(u1) and P̂PVrD ,rD¯(u2) found in Corollary 3.9. Assuming a one-
to-one ratio of cases to controls, 702 cases are required to achieve 90% power
under the alternative hypothesis. This sample size must be multiplied by an
inflation factor to determine the maximum sample size for a group sequential
design (i.e., the sample size if the study does not stop at the interim analyses)
in order for the group sequential design to maintain the same type-I error
rate and power as the fixed-sample design [Jennison and Turnbull (2000)].
Using the gsDesign package in R, we find that the maximum sample size for
group sequential studies with two, three and four stopping times are 724,
737 and 745 cases, respectively. However, as illustrated in the simulation
which follows, the actual sample sizes required in group sequential studies
are generally smaller than these maximum values.
Table 2 presents simulation results using a fixed-sample design and group
sequential designs with two, three and four stopping times. Biomarker values
for the controls were simulated from a standard normal distribution and
biomarker values for the cases were simulated from a normal distribution
with mean and variance chosen to achieve the desired value of NPV(0.6)
and PPV(0.9). The advantages of group sequential designs are clear. The
group sequential designs have similar type-I error rate and power to the
fixed-sample design but with substantially smaller expected sample sizes in
all scenarios.
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6. Discussion. In this paper, we derived asymptotic properties of the
sequential empirical ROC, PPV and NPV curves. We first extended the
work of Hsieh and Turnbull (1996) to the sequential empirical ROC curve
and used these results to develop distribution theory for summaries of the
sequential empirical ROC curve. Next, we considered asymptotic theory for
the sequential empirical PPV curve indexed by the FPF and percentile value
in the entire population. These results were used to develop distribution
theory for summaries of the sequential empirical PPV curve. Asymptotic
theory for the fixed-sample PPV curve, which was previously unavailable,
was developed as a special case.
This work was motivated by the desire to design group sequential diag-
nostic biomarker studies. In Section 5, we illustrated how our results can be
used to design group sequential diagnostic biomarker studies. Our simula-
tion results clearly illustrate the advantages of group sequential designs. In
both cases, the group sequential designs have similar type-I error rate and
power than the fixed-sample designs but with substantially smaller expected
sample size.
An advantage to our approach is that we are able to investigate the joint
behavior of multiple points on the ROC and PPV curve. The primary end-
point of a diagnostic biomarker study may be a single point on the ROC
or PPV curve but other points on the ROC or PPV curve may also be of
interest. The results of Theorems 3.1, 3.5 and 3.6 allow us to apply existing
group sequential methodology for analyzing multiple endpoints to scenarios
where multiple points on the ROC or PPV curve are of interest in a group
sequential diagnostic biomarker study [Liu and Hall (2001)].
We considered estimation of the sequential empirical ROC and PPV curve
under case-control sampling. The asymptotic properties of the sequential
empirical ROC and PPV curve under other sampling schemes are also of
interest. We are currently working on extending the results of this paper to
estimation of the sequential empirical ROC and PPV curve under cohort
and nested case-control sampling.
The theory developed in this paper applies to sequential testing of the
diagnostic accuracy of a continuous test. In many cases, diagnostic tests take
the form of multi-level ordinal data (cancer staging, for example). Methods
exist extending the ROC curve to ordinal data [Dorfman and Alf (1960)]
but further work is needed to verify that group sequential methods can be
applied in these settings.
Response adaptive clinical trials have been proposed as a means to provide
greater flexibility when designing therapeutic clinical trials. Response adap-
tive clinical trials adjust the design characteristics of the study (sample size,
percent randomized to each group, etc.) in response to outcomes for subjects
enrolled earlier in the study. Recently, Zhu and Hu (2010) showed that a class
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of test statistics from a response adaptive clinical trial converges to Brow-
nian Motion when considered sequentially (similar to what we have shown
for the emprical ROC, PPV and NPV curves), which allows existing group
sequential methodology to be applied to response adaptive clinical trials.
Future work will be needed to consider how response adaptive designs can
be applied in the setting of group sequential diagnostic biomarker studies.
APPENDIX: SUPPLEMENTARY RESULTS FOR SECTION 3
A.1. Supplementary results for Section 3.1.
Proof of Theorem 3.1. First, note that
n
−1/2
D [nDrD](R̂OCrD ,rD¯(t)−ROC(t))
= n
−1/2
D [nDrD](SˆD,rD(Sˆ
−1
D¯,rD¯
(t))− SD(S−1D¯ (t)))
= n
−1/2
D [nDrD](SˆD,rD(Sˆ
−1
D¯,rD¯
(t))− SD(Sˆ−1D¯,rD¯(t)))
+ n
−1/2
D [nDrD](SD(Sˆ
−1
D¯,rD¯
(t))− SD(S−1D¯ (t))).
The first term converges to a Kiefer process. We note that
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
|FD¯(Fˆ−1D¯,rD¯(t))− t|
=
nD¯
[nD¯d]
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
[nD¯d]
nD¯
|FD¯(Fˆ−1D¯,rD¯(t))− t|
≤ nD¯
[nD¯d]
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
[nD¯rD¯]
nD¯
|FD¯(Fˆ−1D¯,rD¯(t))− t|.
Therefore,
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
|FD¯(Fˆ−1D¯,rD¯(t))− t| →a.s. 0(A.1)
by the Glivenko–Cantelli theorems [Theorems 1.51 and 1.52 in Cso¨rgo˝ and
Szyszkowicz (1998)] and because
nD¯
[nD¯d]
→ 1d . Furthermore, F−1D¯ (t) will be
continuous by (A1)–(A3) and will be uniformly continuous on [a, b]. There-
fore,
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
|Fˆ−1
D¯,rD¯
(t)− F−1
D¯
(t)| →a.s. 0.(A.2)
We note that due to the continuity of FD¯(x), S
−1
D¯
(t) = F−1
D¯
(1 − t) and
therefore (A.2) also applies to S−1
D¯
(t). From Corollary 1.A in Cso¨rgo˝ and
Szyszkowicz (1998), (A.2) and the uniform continuity of the Kiefer process,
we have
n
−1/2
D [nDrD](SˆD,rD(Sˆ
−1
D¯,rD¯
(t))− SD(Sˆ−1D¯,rD¯(t)))→d K1(ROC(t), rD).(A.3)
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The second term can be rewritten as
n
−1/2
D [nDrD](SD(Sˆ
−1
D¯,rD¯
(t))− SD(S−1D¯ (t)))
=
n
−1/2
D [nDrD]
n
−1/2
D¯
[nD¯rD¯]
(SD(S
−1
D¯
(SD¯(Sˆ
−1
D¯,rD¯
(t))))− SD(S−1D¯ (t)))
SD¯(Sˆ
−1
D¯,rD¯
(t))− t
× n−1/2
D¯
[nD¯rD¯](SD¯(Sˆ
−1
D¯,rD¯
(t))− SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t)))
+
n
−1/2
D [nDrD]
n
−1/2
D¯
[nD¯rD¯]
(SD(S
−1
D¯
(SD¯(Sˆ
−1
D¯,rD¯
(t))))− SD(S−1D¯ (t)))
SD¯(Sˆ
−1
D¯,rD¯
(t))− t
× n−1/2
D¯
[nD¯rD¯](SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t))− t).
By the mean value theorem, there exists a SD¯(S˜
−1
D¯,rD¯
(t)) between SD¯(Sˆ
−1
D¯,rD¯
(t))
and t such that
SD(S
−1
D¯
(SD¯(Sˆ
−1
D¯,rD¯
(t))))− SD(S−1D¯ (t))
SD¯(Sˆ
−1
D¯,rD¯
(t))− t =
fD(S
−1
D¯
(SD¯(S˜
−1
D¯,rD¯
(t))))
fD¯(S
−1
D¯
(SD¯(S˜
−1
D¯,rD¯
(t))))
.
From (A.1), we know that SD¯(Sˆ
−1
D¯,rD¯
(t))→a.s. t, uniformly for t ∈ [a, b], rD ∈
[c,1] and rD¯ ∈ [d,1], and, therefore, SD¯(S˜−1D¯,rD¯(t))→a.s. t, uniformly for t ∈
[a, b], rD ∈ [c,1] and rD¯ ∈ [d,1]. This, along with the uniform continuity of
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
, allows us to conclude that
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
∣∣∣∣
fD(S
−1
D¯
(SD¯(S˜
−1
D¯,rD¯
(t))))
fD¯(S
−1
D¯
(SD¯(S˜
−1
D¯,rD¯
(t))))
− fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
∣∣∣∣→a.s. 0,
which implies
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
∣∣∣∣
SD(S
−1
D¯
(SD¯(Sˆ
−1
D¯,rD¯
(t))))− SD(S−1D¯ (t))
SD¯(Sˆ
−1
D¯,rD¯
(t))− t
− fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
∣∣∣∣(A.4)
→a.s. 0.
For all rD¯ ∈ [d,1],
sup
a≤t≤b
|SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t))− t| ≤a.s. 1
[nD¯rD¯]
.
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Therefore,
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
n
−1/2
D¯
[nD¯rD¯]|SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t))− t| ≤a.s. 1
n
1/2
D¯
and
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤t≤b
n
−1/2
D¯
[nD¯rD¯]|SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t))− t| →a.s. 0.(A.5)
From Corollary 1.A in Cso¨rgo˝ and Szyszkowicz (1998), (A.2) and the uniform
continuity of the Kiefer process, we have
n
−1/2
D¯
[nD¯rD¯](SD¯(Sˆ
−1
D¯,rD¯
(t))− SˆD¯,rD¯(Sˆ
−1
D¯,rD¯
(t)))→d K2(t, rD¯).(A.6)
By (A.4), (A.5), (A.6) and noting that
n
−1/2
D [nDrD ]
n
−1/2
D¯
[nD¯rD¯ ]
→ λ1/2 rDrD¯ , we conclude
that
n
−1/2
D [nDrD](SD(Sˆ
−1
D¯,rD¯
(t))− SD(S−1D¯ (t)))
(A.7)
→d λ1/2 rD
rD¯
(
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
)
K2(t, rD¯).
Summing (A.3) and (A.7) gives the desired result. 
A.2. Supplementary results for Section 3.2.
Corollary A.1. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. For t1, t2, . . . , tJ ∈ (0,1), rD,1, rD,2, . . . , rD,J ∈ (0,1] and rD¯,1, rD¯,2,
. . . , rD¯,J ∈ (0,1], a vector of arbitrary points on the sequential empirical PPV
curve, (P̂PVrD,1,rD¯,1(t1), P̂PVrD,2,rD¯,2(t2), . . . , P̂PVrD,J ,rD¯,J (tJ)), is approxi-
mately multivariate normal with
P̂PVrD,j ,rD¯,j(tj)∼N(PPV(tj), σ2P̂PVrD,j,rD¯,j (tj)
), j = 1,2, . . . , J,
σ2
P̂PVrD,j,rD¯,j (tj )
=
(
t(1− ρ)ρ
(ROC(t)ρ+ t(1− ρ))2
)2
σ2
R̂OCrD,j,rD¯,j (tj)
and
Cov[P̂PVrD,i,rD¯,i(ti), P̂PVrD,j,rD¯,j (tj)]
=
(
ti(1− ρ)ρ
(ROC(ti)ρ+ ti(1− ρ))2
)(
tj(1− ρ)ρ
(ROC(tj)ρ+ tj(1− ρ))2
)
×Cov[R̂OCrD,i,rD¯,i(ti), R̂OCrD,j,rD¯,j (tj)],
where σ2
R̂OCrD,j,rD¯,j (tj)
and Cov[R̂OCrD,i,rD¯,i(ti), R̂OCrD,j ,rD¯,j(tj)] are as de-
fined in Corollary 3.3.
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Proof. Immediate from Theorem 3.5. 
Corollary A.2. Assume (A1)–(A4) hold and let
fD(S
−1
D¯
(t))
fD¯(S
−1
D¯
(t))
be bounded
on [a, b]. For t ∈ (0,1) and J stopping times (P̂PVrD,1,rD¯,1(t), P̂PVrD,2,rD¯,2(t),
. . . , P̂PVrD,J ,rD¯,J (t)), is approximately multivariate normal with
P̂PVrD,i,rD¯,i(t)∼N(PPV(t), σ2P̂PVrD,i,rD¯,i(t)
), i= 1,2, . . . , J,
and
Cov[P̂PVrD,i,rD¯,i(t), P̂PVrD,j,rD¯,j (t)]
= Var[P̂PVrD,j,rD¯,j (t)] = σ
2
P̂PVrD,j,rD¯,j (t)
, ri ≤ rj ,
where σ2
P̂PVrD,j,rD¯,j (t)
is defined as in Corollary A.1.
Proof. Immediate from Corollary A.1. 
A.3. Supplementary results for Section 3.3.
Proof of Theorem 3.6. The proof of Theorem 3.6 follows the proofs
found in Pyke and Shorack (1968). First, note that
n
−1/2
D [nDrD](SˆD,rD(Fˆ
−1
rD ,rD¯
(u))− SD(F−1(u)))
= n
−1/2
D [nDrD](FD(F
−1(u))−FD(Fˆ−1rD ,rD¯(u)))
+ n
−1/2
D [nDrD](FD(Fˆ
−1
rD ,rD¯
(u))− FˆD,rD(Fˆ−1rD ,rD¯(u))).
The first term can be rewritten as
n
−1/2
D [nDrD](FD(F
−1(u))−FD(Fˆ−1rD ,rD¯(u)))
=
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
× n−1/2D [nDrD](u− FˆrD ,rD¯(Fˆ−1rD ,rD¯(u)))
+
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
× ρn−1/2D [nDrD](FˆD,rD(Fˆ−1rD ,rD¯(u))− FD(Fˆ
−1
rD ,rD¯
(u)))
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+
n
−1/2
D [nDrD]
n
−1/2
D¯
[nD¯rD¯]
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
× (1− ρ)n−1/2
D¯
[nD¯rD¯](FˆD¯,rD¯(Fˆ
−1
rD ,rD¯
(u))−FD¯(Fˆ−1rD ,rD¯(u))).
We begin by showing that F (Fˆ−1rD ,rD¯(u)) converges to u uniformly,
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
|F (Fˆ−1rD ,rD¯(u))− u|
≤ sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
|F (Fˆ−1rD ,rD¯(u))− FˆrD ,rD¯(Fˆ
−1
rD ,rD¯
(u))|
+ sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
|FˆrD ,rD¯(Fˆ−1rD ,rD¯(u))− u|.
We note that
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
|F (Fˆ−1rD ,rD¯(u))− FˆrD ,rD¯(Fˆ
−1
rD ,rD¯
(u))|
≤ nD
[nDc]
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
[nDrD]
nD
|FD(Fˆ−1rD ,rD¯(u))− FˆD,rD(Fˆ
−1
rD ,rD¯
(u))|
+
nD¯
[nD¯d]
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
[nD¯rD¯]
nD¯
|FD¯(Fˆ−1rD ,rD¯(u))
− FˆD¯,rD¯(Fˆ
−1
rD ,rD¯
(u))|
→a.s. 0,
by the Glivenko–Cantelli theorems [Theorems 1.51 and 1.52 in Cso¨rgo˝ and
Szyszkowicz (1998)], along with the fact that nD[nDc] →
1
c and
nD¯
[nD¯d]
→ 1d . For
all rD, rD¯ ∈ (0,1]× (0,1],
sup
a≤u≤b
|u− FˆrD,rD¯(Fˆ−1rD ,rD¯(u))| ≤a.s.
(
ρ
[rDnD]
∨ 1− ρ
[nD¯rD¯]
)
.
Therefore,
sup
c≤rD≤1
sup
d≤rD¯≤1
sup
a≤u≤b
|u− FˆrD ,rD¯(Fˆ−1rD ,rD¯(u))|
≤a.s.
(
ρ
[nDc]
∨ 1− ρ
[nD¯d]
)
→ 0,
which implies that
sup
c<rD≤1
sup
d<rD¯≤1
sup
a≤u≤b
|F (Fˆ−1rD ,rD¯(u))− u| →a.s. 0.(A.8)
We note that (A.8) also implies that FD(Fˆ
−1
rD ,rD¯
(u)) and FD¯(Fˆ
−1
rD ,rD¯
(u)) con-
verge uniformly to FD(F
−1(u)) and FD¯(F
−1(u)), respectively, which can be
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seen by noting that the difference between FD(Fˆ
−1
rD ,rD¯
(u)) and FD(F
−1(u))
will always have the same sign as the difference between FD¯(Fˆ
−1
rD ,rD¯
(u))
and FD¯(F
−1(u)).
By the mean value theorem, there exists F (F˜−1rD ,rD¯(u)) between u
and F (Fˆ−1rD ,rD¯(u)), such that
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
=
fD(F
−1(F (F˜−1rD ,rD¯(u))))
f(F−1(F (F˜−1rD ,rD¯(u))))
.
The uniform continuity of fD(F
−1(u))
f(F−1(u))
, combined with the fact that
F (F˜−1rD ,rD¯(u))→a.s. u
uniformly, allows us to conclude
sup
c<rD≤1
sup
d<rD¯≤1
sup
a≤u≤b
∣∣∣∣fD(F
−1(F (F˜−1rD ,rD¯(u))))
f(F−1(F (F˜−1rD ,rD¯(u))))
− fD(F
−1(u))
f(F−1(u))
∣∣∣∣→a.s. 0.(A.9)
For all rD, rD¯ ∈ (0,1]× (0,1],
sup
a≤u≤b
n
−1/2
D [nDrD]|u− FˆrD ,rD¯(Fˆ−1rD ,rD¯(u))|
≤a.s.
(
ρ
n
−1/2
D
∨ [nDrD]
[nD¯rD¯]
1− ρ
n
−1/2
D
)
.
Therefore, as nD→∞ and nD¯→∞,
sup
0<rD≤1
sup
0<rD¯≤1
sup
a≤u≤b
n
−1/2
D [nDrD]|u− FˆrD ,rD¯(Fˆ−1rD ,rD¯(u))| →a.s. 0.
Combining this result with (A.9) allows us to conclude that
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
n
−1/2
D [nDrD](u− FˆrD ,rD¯(Fˆ−1rD ,rD¯(u)))
→a.s. 0.
Corollary 1.A in Cso¨rgo˝ and Szyszkowicz (1998), (A.9) and the uniform
continuity of the Kiefer process allow us to conclude
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
× ρn−1/2D [nDrD](FˆD,rD(Fˆ−1rD ,rD¯(u))−FD(Fˆ
−1
rD ,rD¯
(u)))(A.10)
→d fD(F
−1(u))
f(F−1(u))
ρK1(FD(F
−1(u)), rD
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and
n
−1/2
D [nDrD]
n
−1/2
D¯
[nD¯rD¯]
FD(F
−1(F (Fˆ−1rD ,rD¯(u))))−FD(F−1(u))
F (Fˆ−1rD ,rD¯(u))− u
× (1− ρ)n−1/2
D¯
[nD¯rD¯](FˆD¯,rD¯(Fˆ
−1
rD ,rD¯
(u))−FD¯(Fˆ−1rD ,rD¯(u)))(A.11)
→d
√
λ
rD
rD¯
fD(F
−1(u))
f(F−1(u))
(1− ρ)K2(FD¯(F−1(u)), rD).
The second term converges in distribution to a Kiefer process
n
−1/2
D [nDrD](FD(Fˆ
−1
rD ,rD¯
(u))− FˆD,rD(Fˆ−1rD ,rD¯(u)))
=−n−1/2D [nDrD](FˆD,rD(Fˆ−1rD ,rD¯(u))−FD(Fˆ
−1
rD ,rD¯
(u)))(A.12)
→d −K1(FD(F−1(u)), rD)
by Corollary 1.A in Cso¨rgo˝ and Szyszkowicz (1998). Summing (A.10), (A.11)
and (A.12) gives the desired result. 
Corollary A.3. Assume (A1)–(A4) hold and let fD(F
−1(u))
f(F−1(u))
be bounded
on [a, b]. For u1, u2, . . . , uJ ∈ (0,1), rD,1, rD,2, . . . , rD,J ∈ (0,1] and rD¯,1, rD¯,2,
. . . , rD¯,J ∈ (0,1], a vector of arbitrary points on the sequential empirical PPV
curve, (P̂PVrD,1,rD¯,1(u1), P̂PVrD,2,rD¯,2(u2), . . . , P̂PVrD,J ,rD¯,J (uJ)), is approx-
imately multivariate normal with
P̂PVrD,j,rD¯,j (uj)∼N(PPV(uj), σ2P̂PVrD,j,rD¯,j (uj)
), j = 1,2, . . . , J,
with
Cov[P̂PVrD,1,rD¯,1(u1), P̂PVrD,2,rD¯,2(u2)]
=
(1− ρ)2u1
(1− u1)
fD¯(F
−1(u1))
f(F−1(u1))
fD¯(F
−1(u2))
f(F−1(u2))
× (rD,1 ∧ rD,2)(1−NPV(u1))PPV(u2)
nDrD,1rD,2
+
ρ2u1
(1− u1)
fD(F
−1(u1))
f(F−1(u1))
fD(F
−1(u2))
f(F−1(u2))
× (rD¯,2 ∧ rD¯,2)NPV(u1)(1−PPV(u2))
nDrD,1rD,2
,
when u1 ≤ u2 and
Cov[P̂PVrD,1,rD¯,1(u1), P̂PVrD,2,rD¯,2(u2)]
=
(1− ρ)2u2
(1− u2)
fD¯(F
−1(u1))
f(F−1(u1))
fD¯(F
−1(u2))
f(F−1(u2))
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× (rD,1 ∧ rD,2)(1−NPV(u2))PPV(u1)
nDrD,1rD,2
+
ρ2u2
(1− u2)
fD(F
−1(u1))
f(F−1(u1))
fD(F
−1(u2))
f(F−1(u2))
× (rD¯,2 ∧ rD¯,2)NPV(u2)(1−PPV(u1))
nDrD,1rD,2
,
when u2 ≤ u1, where σ2
P̂PVrD,1,rD¯,1 (u1)
is defined as in Corollary 3.8.
Proof. Immediate from Theorem 3.6. 
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